PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease Reportsautologous blood transfusion
MeSH D001804 - autologous blood transfusion
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D001803:Blood transfusion
0 Companies
0 Drugs
Success rate
D001804: 
Autologous blood transfusion
3 Companies
1 Drug
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
PfizerEpoetin Retacrit  2007-12-18 $340 M Y2023 
RocheEpoetin NeoRecormon  1997-07-16   
Stada ArzneimittelEpoetin Silapo  2007-12-18   
Clinical Trials
Historical Success Rate
Phase 1
0%
0/0
Phase 2
100%
4/4
Phase 3
67%
4/6
Approved: 2Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Pfizer
Epoetin,
Epoetin delta
Roche
Epoetin,
Epoetin delta
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use